Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Clinical trial NCT00623779 · COMPLETED

Trial details

NCT number: NCT00623779
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Persistent or Permanent Non-valvular Atrial Fibrillation

Start date: 2007-10-01
Primary completion: 2008-10-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.